{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:45Z","timestamp":1761513825863},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.semarthrit.2016.05.011","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T04:40:19Z","timestamp":1464928819000},"page":"286-290","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis"],"prefix":"10.1016","volume":"46","author":[{"given":"Asha","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asena","family":"Bahce-Altuntas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhu","family":"Mowrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.semarthrit.2016.05.011_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2010.140582","article-title":"Psoriatic arthritis: update on pathophysiology, assessment and management","volume":"70","author":"Mease","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2016.05.011_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.22185","article-title":"Higher rates and clustering of abnormal lipids, obesity, and diabetes in psoriatic arthritis compared with rheumatoid arthritis","volume":"66","author":"Labitigan","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2016.05.011_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","article-title":"The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2016.05.011_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis","volume":"66","author":"van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2016.05.011_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/jid.2013.447","article-title":"High-density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction","volume":"134","author":"Mehta","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2016.05.011_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2003.018184","article-title":"Dactylitis in psoriatic arthritis: a marker for disease severity?","volume":"64","author":"Brockbank","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"5 suppl 39","key":"10.1016\/j.semarthrit.2016.05.011_bib7","first-page":"8","article-title":"The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2016.05.011_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10067-014-2626-y","article-title":"Remission criteria and activity indices in psoriatic arthritis","volume":"33","author":"Acosta Felquer","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2016.05.011_bib9","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3899\/jrheum.110278","article-title":"Development of a disease severity and responder index for psoriatic arthritis (PsA)\u2014report of the OMERACT 10 PsA special interest group","volume":"38","author":"Coates","year":"2011","journal-title":"J Rheumatol"},{"issue":"suppl 2","key":"10.1016\/j.semarthrit.2016.05.011_bib10","first-page":"ii49","article-title":"Psoriatic arthritis assessment tools in clinical trials","volume":"64","author":"Mease","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2016.05.011_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: predicting risks by levels and ratios","volume":"121","author":"Kinosian","year":"1994","journal-title":"Ann Intern Med"},{"issue":"9468","key":"10.1016\/j.semarthrit.2016.05.011_bib12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.semarthrit.2016.05.011_bib13","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.semarthrit.2016.05.011_bib14","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2016.05.011_bib15","first-page":"1544","article-title":"Patterns of cytokine production in psoriatic synovium","volume":"25","author":"Ritchlin","year":"1998","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2016.05.011_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.2003.018085","article-title":"Early effects of tumour necrosis factor \u03b1 blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis","volume":"63","author":"Goedkoop","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2016.05.011_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study","volume":"113","author":"Park","year":"2002","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2016.05.011_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Lotus","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.semarthrit.2016.05.011_bib19","first-page":"556","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Sin\u00e9ad","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2016.05.011_bib20","article-title":"Anti-psoriatic therapy recovers high-density lipoprotein composition and function","author":"Michael","year":"2013","journal-title":"J Investig Dermatol."},{"issue":"4","key":"10.1016\/j.semarthrit.2016.05.011_bib21","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.semarthrit.2016.05.011_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.atherosclerosis.2014.01.051","article-title":"Modulation of adiponectin as a potential therapeutic strategy","volume":"233","author":"Lim","year":"2014","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.semarthrit.2016.05.011_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0049-0172(92)90017-8","article-title":"Dyslipoproteinemia in the course of active rheumatoid arthritis","volume":"22","author":"Lazarevic","year":"1992","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2016.05.011_bib24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3899\/jrheum.131250","article-title":"Development of a disease activity and responder index for psoriatic arthritis\u2014report of the Psoriatic Arthritis Module at OMERACT 11","volume":"41","author":"Coates","year":"2014","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2016.05.011_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/ard.2009.117945","article-title":"Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis","volume":"69","author":"Nell-Duxneuner","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2016.05.011_bib26","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.37939","article-title":"Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease","volume":"65","author":"Coates","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2016.05.011_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/art.11417","article-title":"Assessment of patients with psoriatic arthritis: a review of currently available measures","volume":"50","author":"Gladman","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216300634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216300634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T06:34:50Z","timestamp":1568010890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216300634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0049017216300634"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.05.011","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}